Chargement de votre page…
Biomedicines
Par Zhao P, Lai S, Dai S et 3 autres.
Contenu en anglais
Amino acid (AA) substitutions in Alzheimer's disease (AD) have been studied almost exclusively at the DNA and RNA levels, and the proteome-level substitution landscape remains largely uncharacterized.
Ward réunit ces articles dans la même app que vos cartes et vos questions. Un seul compte gratuit pour Ward, Suture, Osler et Prognia.
We applied an open-search substitutomics pipeline (PIPI-C with Comet re-scoring, 1% PSM-level FDR) to two independent AD brain proteomic datasets, the AMP-AD superior temporal gyrus cohort (244 individuals) and PXD013753, excluding substitutions whose mass shifts coincide with common post-translational modifications.
We quantified 789 substitution-bearing peptidoforms from 185 proteins, corresponding to 784 protein-level substitution events. N > M was the most frequent N > X substitution in both datasets. In an institution-stratified case-control meta-analysis, 138 peptidoforms were more and 142 less abundant in AD than in neuropathological controls. Of 774 genome-mappable events, 710 (91.7%) were recorded in neither UniProt nor gnomAD, and only five matched a population variant with allele frequency ≥ 0.1%. The unrestricted search recovered six literature-reported sites in GFAP, ACTG1, and HBB.
Proteome-level profiling reveals substitution events in AD brains that catalogued germline variation does not explain; their molecular origin requires orthogonal validation.
Publié dans Biomedicines. Le résumé est reproduit tel qu’il a été publié et reste l’œuvre de ses auteurs ; lisez l’article complet à la source.
Prognia référence cet article à des fins de documentation et de formation. Il ne constitue pas un avis médical. Lisez toujours l’original et suivez les recommandations en vigueur et les protocoles locaux avant d’agir.
